Analyst Ratings for Jazz Pharmaceuticals (JAZZ)
JAZZ Rating Summary
JAZZ Price Target Summary
- Highest: $322.00 (Morgan Stanley)
- Lowest: $227.00 (Raymond James)
- Average: $283.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$283.50 (+16.2%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
Avg. $ Target:
$283.50 (+16.2%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/16/2026 | Canaccord » Updated 9/1/2026 |
Gary Newman | New Coverage | Buy (N/A) |
300.00 (N/A) |
239.32 (244.04) |
1.97% | Details |
| 6/9/2026 | Truist Securities » Updated 8/26/2026 |
Gregory Renza | New Coverage | Buy (N/A) |
281.00 (264.00) |
232.04 (244.04) |
5.17% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
